Provention Bio (PRVB) rises over 10% today
Provention Bio (PRVB) currently trades at $11.20 and has grown by 10.45% today. PRVB went up $1.06 from the previous closing price of $10.14. The high forecast for Provention Bio is $30.00 and the low is $10.00. The company’s market cap is $534.39 million with a 52 week high of $22.85 and a 52 week low of $2.89. PRVB has changed in price by 8.05 per share in the last 12 months.
Provention Bio has a weak EPS of -1.06. This means the company lost $-1.06 per share after paying dividends, this can indicate that the stock is a risky investment. EPS is calculated as a company’s profit divided by the outstanding shares of its common stock. The resulting number serves as an indicator of a company’s profitability. It is common for a company to report EPS that is adjusted for extraordinary items and potential share dilution. Based on this information, investorsQ rates this stock 5 out of 10. We give it this rating based on current information written in this article.
About Provention Bio:
Provention Bio, Inc. operates as a biopharmaceutical company. The Company focuses on development of novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease. Provention Bio serves patients in the State of New Jersey.